Updated: May 19, 2026

School of Medicine At Mount Sinai Icahn

WGSGeneDx Holdings Corp.SEC CIK: 0001883139
Estimated Net Worth
$191 Million97.7%vs Last Year
Last Updated: May 19, 2026 11:51 PM EST

Transaction Summary

Total Transactions8
Buy-Sell Ratio1.00
Buy Transactions2
Sell Transactions2

Transaction Volume

Total Volume-$40.33M
Net Volume$110.33M
Buy Volume$35.00M
Sell Volume-$75.33M

Trade Analysis

AVG Trade Size-$4.55M
Largest Trade$25.00M
Most Active MonthApr
Most Active Year2024

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading chart

Monthly Trading Pattern

Loading chart

Past Insider Trading and Trends

School of Medicine At Mount Sinai Icahn has an estimated net worth of $191 Million. This is based on reported shares across multiple companies, which include GeneDx Holdings Corp., and Renalytix plc.



2024 was School of Medicine At Mount Sinai Icahn's most active year for acquiring shares with 2 total transactions. School of Medicine At Mount Sinai Icahn's most active month to acquire stocks was the month of March. 2024 was School of Medicine At Mount Sinai Icahn's most active year for disposing of shares, totalling 3 transactions. School of Medicine At Mount Sinai Icahn's most active month to dispose stocks was the month of October. 2022 saw School of Medicine At Mount Sinai Icahn paying a total of $25,000,000.00 for 6,250,000 shares, this is the most they've acquired in one year. In 2024 School of Medicine At Mount Sinai Icahn cashed out on 1,012,941 shares for a total of $75,328,722.68, their largest year based on trade value.

Holdings & Transactions

Loading…
Loading…